Skip to main content

Advertisement

Log in

Lebertransplantation beim hilären Cholangiokarzinom

Liver transplantation for hilar cholangiocarcinoma

  • Leitthema
  • Published:
Der Chirurg Aims and scope Submit manuscript

Zusammenfassung

Lokal nichtresektable hiläre Cholangiokarzinome können durch Lebertransplantation kurativ therapiert werden. Die ursprünglich schlechten Ergebnisse nach Transplantation haben sich durch die Etablierung neoadjuvanter Therapieprotokolle und veränderte Strategien in der immunsuppressiven Therapie deutlich verbessert, sodass perihiläre Cholangiokarzinome nun wieder als Transplantationsindikation anerkannt werden. Geeignete Patienten sollten streng selektioniert werden. Die vorliegende Arbeit fasst den aktuellen Stand, Empfehlungen und die Ergebnisse der Lebertransplantation bei diesen Patienten zusammen.

Abstract

Local non-resectable, hilar cholangiocarcinoma can be cured by performing a liver transplantation. The initially poor results after transplantation have significantly improved since neoadjuvant therapy protocols have been established. Therefore, hilar cholangiocarcinoma is now an accepted indication for liver transplantation in selected patients. This article summarizes the current state, recommendations and results of liver transplantation for these patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1
Abb. 2
Abb. 3
Abb. 4

Literatur

  1. Seehofer D, Thelen A, Neumann UP et al (2009) Extended bile duct resection and [corrected] liver and transplantation in patients with hilar cholangiocarcinoma: long-term results. Liver Transpl 15:1499–1507

    Article  PubMed  Google Scholar 

  2. Starzl TE, Porter KA, Putnam CW (1997) Orthotopic liver transplantation in ninety-three patients. Surg Gynecol Obstet 142:487–505

    Google Scholar 

  3. Shaib Y, El-Serag HB (2004) The epidemiology of cholangiocarcinoma. Semin Liver Dis 24:115–125

    Article  PubMed  Google Scholar 

  4. Broomé U, Löfberg R, Veress B, Eriksson LS (1995) Primary sclerosing cholangitis and ulcerative colitis: evidence for increased neoplastic potential. Hepatology 22:1404–1408

    PubMed  Google Scholar 

  5. Karlsen TH, Schrumpf E, Boberg KM (2010) Primary sclerosing cholangitis. Best Pract Res Clin Gastroenterol 24:655–666

    Article  PubMed  CAS  Google Scholar 

  6. Blechacz BRA, Gores GJ (2008) Cholangiocarcinoma. Clin Liver Dis 12:131–150

    Article  PubMed  Google Scholar 

  7. De Kerckhove L, De Meyer M, Verbaandert C et al (2006) The place of liver transplantation in Caroli’s disease and syndrome. Transpl Int 19:381–388

    Article  Google Scholar 

  8. Ulrich F, Pratschke J, Pascher A (2008) Long-term outcome of liver resection and transplantation for caroli disease and syndrome. Ann Surg 247:357–364

    Article  PubMed  Google Scholar 

  9. Jarnagin WR, Fong Y, DeMatteo RP et al (2001) Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg 234:507–519

    Article  PubMed  CAS  Google Scholar 

  10. Deoliveira ML, Schulick RD, Nimura Y et al (2011) New staging system and a registry for perihilar cholangiocarcinoma. Hepatology 53:1363–1371

    Article  PubMed  Google Scholar 

  11. Cucchetti A, Vitale A, Gaudio MD et al (2010) Harm and benefits of primary liver resection and salvage transplantation for hepatocellular carcinoma. Am J Transplant 10:619–627

    Article  PubMed  CAS  Google Scholar 

  12. Zhang Y, Uchida M, Abe T et al (1999) Intrahepatic peripheral cholangiocarcinoma: comparison of dynamic CT and dynamic MRI. J Comput Assist Tomogr 23:670

    Article  PubMed  CAS  Google Scholar 

  13. Manfredi R, Barbaro B, Masselli G et al (2004) Magnetic resonance imaging of cholangiocarcinoma. Semin Liver Dis 24:155–164

    Article  PubMed  Google Scholar 

  14. Rösch T, Meining A, Frühmorgen S et al (2002) A prospective comparison of the diagnostic accuracy of ERCP, MRCP, CT, and EUS in biliary strictures. Gastrointest Endosc 55:870–876

    Article  PubMed  Google Scholar 

  15. Kato T, Tsukamoto E, Kuge Y et al (2002) Clinical role of 18 F-FDG PET for initial staging of patients with extrahepatic bile duct cancer. Eur J Nucl Med Mol Imaging 29:1047–1054

    Article  PubMed  CAS  Google Scholar 

  16. Breitenstein S, Apestegui C, Clavien PA (2008) Positron emission tomography (PET) for cholangiocarcinoma. HPB (Oxford) 10:120–121

  17. Khan SA, Thomas HC, Davidson BR, Taylor-Robinson SD (2005) Cholangiocarcinoma. Lancet 366:1303–1314

    Article  PubMed  Google Scholar 

  18. Heimbach JK, Gores GJ, Haddock MG et al (2006) Predictors of disease recurrence following neoadjuvant chemoradiotherapy and liver transplantation for unresectable perihilar cholangiocarcinoma. Transplantation 82:1703–1707

    Article  PubMed  CAS  Google Scholar 

  19. Fan L, He F, Liu H et al (2011) CD133: a potential indicator for differentiation and prognosis of human cholangiocarcinoma. BMC Cancer 11:320

    Article  PubMed  Google Scholar 

  20. Boonjaraspinyo S, Boonmars T, Kaewkes S et al (2011) Down-regulated expression of hsp70 in correlation with clinicopathology of cholangiocarcinoma. Pathol Oncol Res 13 [Epub ahead of print]

  21. Subimerb C, Pinlaor S, Khuntikeo N et al (2010) Tissue invasive macrophage density is correlated with prognosis in cholangiocarcinoma. Mol Med Report 3:597–605

    PubMed  CAS  Google Scholar 

  22. Tamada K, Ushio J, Sugano K (2011) Endoscopic diagnosis of extrahepatic bile duct carcinoma: advances and current limitations. World J Clin Oncol 2:203–216

    PubMed  Google Scholar 

  23. Heimbach JK, Sanchez W, Rosen CB, Gores GJ (2011) Trans-peritoneal fine needle aspiration biopsy of hilar cholangiocarcinoma is associated with disease dissemination. HPB (Oxford) 3:356–360

    Google Scholar 

  24. Hong JC, Petrowsky H, Kaldas FM et al (2011) Predictive index for tumor recurrence after liver transplantation for locally advanced intrahepatic and hilar cholangiocarcinoma. J Am Coll Surg 212:514–21

    Article  PubMed  Google Scholar 

  25. Baere T de, Denys A, Madoff DC (2007) Preoperative portal vein embolization: indications and technical considerations. Tech Vasc Interv Radiol 10:67–78

    Article  PubMed  Google Scholar 

  26. Makuuchi M, Donadon M, Torzilli G (2008) Hepatic resection for hepatocellular carcinoma in cirrhosis. Ann Ital Chir 79:111–115

    PubMed  Google Scholar 

  27. Stockmann M, Lock JF, Malinowski M et al (2010) The LiMAx test: a new liver function test for predicting postoperative outcome in liver surgery. HPB (Oxford) 12:139–146

    Google Scholar 

  28. Neuhaus P, Thelen A, Jonas S et al (2011) Oncological superiority of hilar en bloc resection for the treatment of hilar cholangiocarcinoma. Ann Surg Oncol [Epub ahead of print]

  29. Bundesärztekammer (2010) Bundesärztekammer – Richtlinien zur Transplantationsmedizin. Bundesarztekammer

  30. Schlitt HJ, Loss M, Scherer MN et al (2011) Current developments in liver transplantation in Germany: MELD-based organ allocation and incentives for transplant centres. Z Gastroenterol 49:30–38

    Article  PubMed  CAS  Google Scholar 

  31. Biggins SW, Bambha K (2006) MELD-based liver allocation: who is underserved? Semin Liver Dis 26:211–220

    Article  PubMed  Google Scholar 

  32. Gores GJ, Gish RG, Sudan D, Rosen CB (2006) MELD exception study group. Model for end-stage liver disease (MELD) exception for cholangiocarcinoma or biliary dysplasia. Liver Transpl 12(Suppl 3):95–97

    Article  Google Scholar 

  33. Pinson CW, Moore DE (2003) Liver transplantation is not indicated for cholangiocarcinoma. HPB (Oxford) 5:203–205

  34. Jeyarajah DR, Klintmalm GB (1998) Is liver transplantation indicated for cholangiocarcinoma? J Hepatobiliary Pancreat Surg 5:48–51

    Article  PubMed  CAS  Google Scholar 

  35. Robles R, Figueras J, Turrión VS et al (2004) Spanish experience in liver transplantation for hilar and peripheral cholangiocarcinoma. Ann Surg 239:265–271

    Article  PubMed  Google Scholar 

  36. Heimbach JK, Gores GJ, Haddock MG et al (2004) Liver transplantation for unresectable perihilar cholangiocarcinoma. Semin Liver Dis 24:201–207

    Article  PubMed  Google Scholar 

  37. Mantel HTJ, Rosen CB, Heimbach JK et al (2007) Vascular complications after orthotopic liver transplantation after neoadjuvant therapy for hilar cholangiocarcinoma. Liver Transpl 10:1372–1381

    Article  Google Scholar 

  38. Grossman EJ, Millis JM (2010) Liver transplantation for non-hepatocellular carcinoma malignancy: indications, limitations, and analysis of the current literature. Liver Transpl 8:930–942

    Article  Google Scholar 

  39. Settmacher U, Götz M, Rahmel A et al (2011) Living donor liver transplantation in adults in the MELD era in Germany – a multi-center retrospective analysis. Transpl Int 24:904–911

    Article  PubMed  Google Scholar 

  40. Jonas S, Mittler J, Pascher A et al (2005) Extended indications in living-donor liver transplantation: bile duct cancer. Transplantation 80(Suppl 1):101–104

    Article  Google Scholar 

  41. Neuhaus P, Jonas S et al (1999) Extended resections for hilar cholangiocarcinoma. Ann Surg 230:808–819

    Article  PubMed  CAS  Google Scholar 

  42. Starzl TE, Todo S, Tzakis A et al (1989) Abdominal organ cluster transplantation for the treatment of upper abdominal malignancies. Ann Surg 210:374–386

    Article  PubMed  CAS  Google Scholar 

  43. Jonas S, Kling N, Guckelberger O et al (1998) Orthotopic liver transplantation after extended bile duct resection as treatment of hilar cholangiocarcinoma. First long-terms results. Transpl Int 11(Suppl 1):206–208

    Google Scholar 

  44. Rea DJ, Heimbach JK, Rosen CB et al (2005) Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma. Ann Surg 242:451

    PubMed  Google Scholar 

  45. Wu Y, Johlin FC, Rayhill SC et al (2008) Long-term, tumor-free survival after radiotherapy combining hepatectomy-Whipple en bloc and orthotopic liver transplantation for early-stage hilar cholangiocarcinoma. Liver Transpl 3:279–286

    Article  Google Scholar 

  46. Soejima Y, Ueda S, Sanefuji K et al (2008) Sequential pancreaticoduodenectomy after living donor liver transplantation for cholangiocarcinoma. Am J Transplant 10:2158–2162

    Article  Google Scholar 

  47. Alessiani M, Tzakis A, Todo S et al (1995) Assessment of five-year experience with abdominal organ cluster transplantation. J Am Coll Surg 1801:1–9

    Google Scholar 

  48. Farmer DG, Shaked A, Colonna JO et al (1993) Radical resection combined with liver transplantation for foregut tumors. Am Surg 59:806–812

    PubMed  CAS  Google Scholar 

  49. Rosen CB, Heimbach JK, Gores GJ (2010) Liver transplantation for cholangiocarcinoma. Transpl Int 23:692–697

    Article  PubMed  Google Scholar 

  50. Heimbach JK (2008) Successful liver transplantation for hilar cholangiocarcinoma. Curr Opin Gastroenterol 24:384–388

    Article  PubMed  Google Scholar 

  51. Sotiropoulos GC, Lang H, Niebel W et al (2004) 10-year tumor-free survival after intraoperative radiation therapy and secondary liver transplantation for hilar cholangiocarcinoma. Transplantation 77:1625

    Article  PubMed  Google Scholar 

  52. Gu J, Bai J, Shi X et al (2011) Efficacy and safety of liver transplantation for patients with cholangiocarcinoma: a systematic review and meta-analysis. Int J Cancer [Epub ahead of print]

  53. Rizell M, Andersson M, Cahlin C et al (2008) Effects of the mTOR inhibitor sirolimus in patients with hepatocellular and cholangiocellular cancer. Int J Clin Oncol 13:66–70

    Article  PubMed  CAS  Google Scholar 

  54. Castroagudín JF, Molina E, Tomé S et al (2009) Safety of an immunosuppressant protocol based on sirolimus in liver transplant recipients with malignancies or high risk of tumor recurrence. Transplant Proc 41:1003–1004

    Article  PubMed  Google Scholar 

  55. Shimoda M (2001) Liver transplantation for cholangiocellular carcinoma: analysis of a single-center experience and review of the literature. Liver Transpl 7:1023–1033

    Article  PubMed  CAS  Google Scholar 

  56. Meyer CG, Penn I, James L (2000) Liver transplantation for cholangiocarcinoma: results in 207 patients. Transplantation 69:1633–1637

    Article  PubMed  CAS  Google Scholar 

  57. Soderdahl G, Barkholt L, Hentschke P et al (2003) Liver transplantation followed by adjuvant nonmyeloablative hemopoietic stem cell transplantation for advanced primary liver cancer in humans. Transplantation 75:1061–1066

    Article  PubMed  Google Scholar 

Download references

Interessenkonflikt

Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to F. Rauchfuß.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rauchfuß, F., Uteß, F., Schüle, S. et al. Lebertransplantation beim hilären Cholangiokarzinom. Chirurg 83, 229–237 (2012). https://doi.org/10.1007/s00104-011-2178-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00104-011-2178-5

Schlüsselwörter

Keywords

Navigation